Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results

Go back to Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results
(NASDAQ: VIR) Delayed: 9.57 +0.41 (4.48%)
Previous Close $9.16    52 Week High
Open $9.29    52 Week Low
Day High $9.63    P/E N/A 
Day Low $9.16    EPS
Volume 1,792,342